These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35626160)

  • 1. Selection Criteria for Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Treatment in Patients with Peritoneal Metastases.
    Balmer A; Clerc D; Toussaint L; Sgarbura O; Taïbi A; Hübner M; Teixeira Farinha H
    Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35626160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of cytology in patients undergoing pressurized intraperitoneal aerosol chemotherapy (PIPAC) treatment for peritoneal carcinomatosis.
    Deban M; Châtelain J; Fasquelle F; Clerc D; Toussaint L; Hübner M; Teixeira Farinha H
    Pleura Peritoneum; 2023 Jun; 8(2):75-81. PubMed ID: 37304163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reasons for stopping Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC): A retrospective study to improve future patient selection.
    Ezanno AC; Malgras B; Conan PL; Aime A; Fawaz J; Picchi H; Doat S; Pocard M
    PLoS One; 2023; 18(11):e0287785. PubMed ID: 38033087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Outcome for Patients Managed with Low-Dose Cisplatin and Doxorubicin Delivered as Pressurized Intraperitoneal Aerosol Chemotherapy for Unresectable Peritoneal Metastases of Gastric Cancer.
    Sindayigaya R; Dogan C; Demtröder CR; Fischer B; Karam E; Buggisch JR; Tempfer CB; Lecomte T; Ouaissi M; Giger-Pabst U
    Ann Surg Oncol; 2022 Jan; 29(1):112-123. PubMed ID: 34611790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial experience of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in a French hyperthermic intraperitoneal chemotherapy (HIPEC) expert center.
    Ceribelli C; Debs T; Chevallier A; Piche MA; Bereder JM
    Surg Endosc; 2020 Jun; 34(6):2803-2806. PubMed ID: 32166545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Descriptive review of current practices and prognostic factors in patients with ovarian cancer treated by pressurized intraperitoneal aerosol chemotherapy (PIPAC): a multicentric, retrospective, cohort of 234 patients.
    Kefleyesus A; Bhatt A; Escayola C; Khomyakov V; Hübner M; Reymond MA; Thieme R; Sgarbura O; Willaert W; Ceelen W; Di Giorgio A; Vizzielli G; Glehen O; Robella M; Bakrin N
    Front Oncol; 2023; 13():1204886. PubMed ID: 37692848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concentrations of cisplatin and doxorubicin in ascites and peritoneal tumor nodules before and after pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with peritoneal metastasis.
    Tempfer CB; Hilal Z; Dogan A; Petersen M; Rezniczek GA
    Eur J Surg Oncol; 2018 Jul; 44(7):1112-1117. PubMed ID: 29753612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pressurized intraperitoneal aerosol chemotherapy with low-dose cisplatin and doxorubicin (PIPAC C/D) in patients with gastric cancer and peritoneal metastasis: a phase II study.
    Struller F; Horvath P; Solass W; Weinreich FJ; Strumberg D; Kokkalis MK; Fischer I; Meisner C; Königsrainer A; Reymond MA
    Ther Adv Med Oncol; 2019; 11():1758835919846402. PubMed ID: 31205501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PIPAC-OV3: A multicenter, open-label, randomized, two-arm phase III trial of the effect on progression-free survival of cisplatin and doxorubicin as Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) vs. chemotherapy alone in patients with platinum-resistant recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer.
    Bakrin N; Tempfer C; Scambia G; De Simone M; Gabriel B; Grischke EM; Rau B
    Pleura Peritoneum; 2018 Sep; 3(3):20180114. PubMed ID: 30911662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) with cisplatin and doxorubicin in combination with FOLFOX chemotherapy as a first-line treatment for gastric cancer patients with peritoneal metastases: single-arm phase II study.
    Luksta M; Bausys A; Bickaite K; Rackauskas R; Paskonis M; Luksaite-Lukste R; Ranceva A; Stulpinas R; Brasiuniene B; Baltruskeviciene E; Lachej N; Sabaliauskaite R; Bausys R; Tulyte S; Strupas K
    BMC Cancer; 2023 Oct; 23(1):1032. PubMed ID: 37875869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pressurized IntraPeritoneal Aerosol Chemotherapy vs. intravenous chemotherapy for unresectable peritoneal metastases secondary to platinum resistant ovarian cancer - study protocol for a randomized control trial.
    Somashekhar SP; Ashwin KR; Rauthan A; Rohit KC
    Pleura Peritoneum; 2019 Mar; 4(1):20180111. PubMed ID: 31198851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) in patients with peritoneal metastasized colorectal, appendiceal and small bowel cancer.
    Gockel I; Jansen-Winkeln B; Haase L; Niebisch S; Moulla Y; Lyros O; Lordick F; Schierle K; Wittekind C; Thieme R
    Tumori; 2020 Feb; 106(1):70-78. PubMed ID: 31469058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of Treatment Response after Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) for Appendiceal Peritoneal Metastases.
    Somashekhar SP; Abba J; Sgarbura O; Alyami M; Teixeira Farinha H; Rao RG; Willaert W; Hübner M;
    Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I/II study of oxaliplatin dose escalation via a laparoscopic approach using pressurized aerosol intraperitoneal chemotherapy (PIPOX trial) for nonresectable peritoneal metastases of digestive cancers (stomach, small bowel and colorectal): Rationale and design.
    Dumont F; Senellart H; Pein F; Campion L; Glehen O; Goere D; Pocard M; Thibaudeau E
    Pleura Peritoneum; 2018 Sep; 3(3):20180120. PubMed ID: 30911664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pressurized Intraperitoneal Aerosol Chemotherapy for Colorectal Peritoneal Metastases.
    Tabchouri N; Buggisch J; Demtröder CR; Thiery J; Rezniczek G; Tempfer CB; Fischer B; Dogan C; Lecomte T; Ouaissi M; Giger-Pabst U
    Ann Surg Oncol; 2021 Sep; 28(9):5275-5286. PubMed ID: 33471267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment Response After Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) for Peritoneal Metastases of Colorectal Originf.
    Hübner M; Somashekhar SP; Teixeira Farinha H; Abba J; Rao RG; Alyami M; Willaert W
    Ann Surg Open; 2022 Dec; 3(4):e203. PubMed ID: 37600288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in multimodal therapy for patients with oligometastatic peritoneal gastric cancer: a randomized multicenter phase III trial PIPAC VEROne.
    Casella F; Bencivenga M; Rosati R; Fumagalli UR; Marrelli D; Pacelli F; Macrì A; Donini A; Torroni L; Pavarana M; De Manzoni G
    Pleura Peritoneum; 2022 Sep; 7(3):135-141. PubMed ID: 36159218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pressurized Intraperitoneal Aerosol Chemotherapy with Cisplatin and Doxorubicin in Women with Peritoneal Carcinomatosis: A Cohort Study.
    Tempfer CB; Rezniczek GA; Ende P; Solass W; Reymond MA
    Anticancer Res; 2015 Dec; 35(12):6723-9. PubMed ID: 26637888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Peritoneal Metastasis with Pressurized Intraperitoneal Aerosol Chemotherapy: Results from the Prospective PIPAC-OPC2 Study.
    Graversen M; Detlefsen S; Ainsworth AP; Fristrup CW; Knudsen AO; Pfeiffer P; Tarpgaard LS; Mortensen MB
    Ann Surg Oncol; 2023 May; 30(5):2634-2644. PubMed ID: 36602663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-resectable Malignant Peritoneal Mesothelioma Treated with Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Plus Systemic Chemotherapy Could Lead to Secondary Complete Cytoreductive Surgery: A Cohort Study.
    Kepenekian V; Péron J; You B; Bonnefoy I; Villeneuve L; Alyami M; Bakrin N; Rousset P; Benzerdjeb N; Glehen O
    Ann Surg Oncol; 2022 Mar; 29(3):2104-2113. PubMed ID: 34713369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.